SCHEMBL3869494

SCHEMBL3869494

CCCCCCCC(=O)OCC(C)COC(=O)CCCCCCC

nearest known ligand 0.76

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.76
LMNA P02545 4/20 0.68
ALDH1A1 P00352 1/20 0.68
KDM4E B2RXH2 1/20 0.66
DUSP3 P51452 1/20 0.66
MEN1 O00255 1/20 0.66
KMT2A Q03164 1/20 0.66
DGKA P23743 1/20 0.64
PRKCA P17252 3/20 0.62
PRKCE Q02156 1/20 0.62
PRKCQ Q04759 1/20 0.62
PRKCD Q05655 1/20 0.62
PAM P19021 2/20 0.58
CYP3A4 P08684 1/20 0.58
TSHR P16473 1/20 0.58
ATM Q13315 1/20 0.58
TDP1 Q9NUW8 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3872650 1.00 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL3872781 1.00 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL19676374 1.00 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL19123313 1.00 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL19123805 1.00 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL13620523 1.00 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL3877811 1.00 MAPT (0.76) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL14201918 0.93 MAPT (0.67) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL15985180 0.92 MAPT (0.71) MAPTLMNAALDH1A1KDM4EDUSP3
SCHEMBL4624898 0.92 MAPT (0.71) MAPTLMNAALDH1A1KDM4EDUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357133-A1 NANOMATERIALS COMPRISING CARBONATES BEAM THERAPEUTICS INC. 2023-11-09 US disclosed
EP-4223285-A2 METHOD OF ENCAPSULATING A NUCLEIC ACID IN A LIPID NANOPARTICLE HOST Novartis AG (CH) 2023-08-09 EP disclosed
EP-3623361-A1 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS Novartis AG (CH) 2020-03-18 EP disclosed
EP-3351611-A1 REFRIGERATION MACHINE OIL, COMPOSITION FOR REFRIGERATION MACHINES, AND COMPRESSION-TYPE REFRIGERATION MACHINE Idemitsu Kosan Co., Ltd (JP) 2018-07-25 EP disclosed
US-20170196809-A1 METHOD OF ENCAPSULATING A NUCLEIC ACID IN A LIPID NANOPARTICLE HOST NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. 2017-07-13 US disclosed
US-7517838-B2 Lubricating oil for bearing NEW JAPAN CHEMICAL CO., LTD. (JP) 2009-04-14 US disclosed
US-20060019840-A1 Lubricating oil for bearing NEW JAPAN CHEMICAL CO., LTD. (JP) 2006-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170196809-A1 METHOD OF ENCAPSULATING A NUCLEIC ACID IN A LIPID NANOPARTICLE HOST POLN, POLRMT, RNGTT MAPT 1679/4885LMNA 700/4885ALDH1A1 2314/4885
US-20230357133-A1 NANOMATERIALS COMPRISING CARBONATES PHOSPHO1, CA13, SGMS2 MAPT 1135/4885LMNA 211/4885ALDH1A1 3544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.